Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Glenmark shines with arm receiving USFDA's final approval for Hydrocortisone Valerate Cream

15-Oct2018

Glenmark shines with arm receiving USFDA's final approval for Hydrocortisone Valerate Cream

Glenmark Pharmaceuticals is currently trading at Rs. 610.00, up by 9.15 points or 1.52% from its previous closing of Rs. 600.85 on the BSE.

The scrip opened at Rs. 606.90 and has touched a high and low of Rs. 615.45 and Rs. 596.35 respectively. So far 57685 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 711.55 on 10-Sep-2018 and a 52 week low of Rs. 483.60 on 30-May-2018.

Last one week high and low of the scrip stood at Rs. 615.45 and Rs. 575.00 respectively. The current market cap of the company is Rs. 17174.16 crore.

The promoters holding in the company stood at 46.54%, while Institutions and Non-Institutions held 38.19% and 15.28% respectively.Glenmark Pharmaceuticals' subsidiary -- Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Hydrocortisone Valerate Cream USP, 0.2%, a generic version of Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc.

According to IQVIA sales data for the 12-month period ending August 2018, the Westcort Cream, 0.2% market achieved annual sales of approximately $17.0 million.
The company's current portfolio consists of 139 products authorized for distribution in the US marketplace and 60 ANDA's pending approval with the USFDA. In addition to these internal filings, the compnay continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Related News

View all news

ITC surges on reporting 9% rise in Q3 net profit

ITC is currently trading at Rs. 282.25, up by 4.55 points or 1.64% from its previous closing of Rs. 277.70 on the BSE.The scrip opened at Rs. 279.45 and has touched a high and low of Rs. 282.40 and Rs.......

Interglobe Aviation shines despite reporting 75% fall in Q3 net profit

Interglobe Aviation is currently trading at Rs. 1153.00, up by 45.05 points or 3.98% from its previous closing of Rs. 1107.95 on the BSE.The scrip opened at Rs. 1077.00 and has touched a high and low of......

Apollo Micro System advances on bagging order worth Rs 129.99 million

Apollo Micro Systems is currently trading at Rs. 123.10, up by 1.35 points or 1.11% from its previous closing of Rs. 121.75 on the BSE.The scrip opened at Rs. 128.00 and has touched a high and low of Rs.......

Top News

View all news

Spice Mobility incorporates foreign subsidiary in Nepal

Spice Mobility has incorporated 'Digispice Nepal', a 100% foreign subsidiary of the company, in Nepal. The main object of the company is to operate in the information technology industry and provide software......

CARE assigns 'Al+' rating to EID Parry's CP

Credit rating agency, CARE has assigned rating of 'Al+' to EID Parry's Commercial Paper (CP) worth Rs 950 crore. The rating assigned to the CP factors in strong parentage of EID, benefits derived from......

Hathway Cable & Datacom reports 73% fall in Q3 net profit

Hathway Cable & Datacom has reported results for third quarter ended December 31, 2018.The company has reported 73.02% fall in its net profit at Rs 6.44 crore for the quarter under review as compared......